Cargando…
Locally advanced triple negative breast cancer arising from fibroadenoma with complete response to neoadjuvant chemotherapy: A case report
INTRODUCTION: Breast cancer arising from benign fibroadenoma (FA) is rare. The histological type of the former was either carcinoma in situ or early-stage invasive breast carcinoma with hormone receptor positive/HER2 (human epidermal growth factor receptor-2)-negative phenotype. Meanwhile, advanced...
Autores principales: | Shiino, Sho, Yoshida, Masayuki, Tokura, Momoko, Watase, Chikashi, Murata, Takeshi, Jimbo, Kenjiro, Takayama, Shin, Suto, Akihiko, Satomi, Kaishi, Miyagi Maeshima, Akiko, Kikuchi, Mari, Uchiyama, Nachiko, Kinoshita, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078443/ https://www.ncbi.nlm.nih.gov/pubmed/32193143 http://dx.doi.org/10.1016/j.ijscr.2020.02.059 |
Ejemplares similares
-
Preliminary experiences of PET/MRI in predicting complete response in patients with breast cancer treated with neoadjuvant chemotherapy
por: Sekine, Chikako, et al.
Publicado: (2022) -
Spontaneous regression of occult breast cancer with axillary lymph node metastasis: A case report
por: Takayama, Shin, et al.
Publicado: (2019) -
A prediction model for distant metastasis after isolated locoregional recurrence of breast cancer
por: Murata, Takeshi, et al.
Publicado: (2023) -
Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study
por: Murata, Takeshi, et al.
Publicado: (2022) -
Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer
por: Shikata, Shohei, et al.
Publicado: (2023)